Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126471521 | 12647152 | 1 | I | 20151022 | 0 | 20160811 | 20160811 | DIR | 58.00 | YR | F | N | 153.00000 | LBS | 20160427 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126471521 | 12647152 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | INJECTED EVERY 3 MONTHS | N | D | 0 | SUSPENSION FOR INJECTION | ||||||||
| 126471521 | 12647152 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 4 | C | RALOXIFENE. | RALOXIFENE | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 6 | C | RESTASIS | CYCLOSPORINE | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 8 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 10 | C | SUMATRIPTAN. | SUMATRIPTAN | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 12 | C | MVI | VITAMINS | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 14 | C | B STRESS | 2 | 0 | |||||||||||||
| 126471521 | 12647152 | 16 | C | CALCIUM WITH D | CALCIUMVITAMIN D | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 18 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 20 | C | MOTRIN | IBUPROFEN | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 22 | C | ZINC | ZINCINC CHLORIDE | 1 | 0 | ||||||||||||
| 126471521 | 12647152 | 24 | C | MAGNESIUM | MAGNESIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126471521 | 12647152 | 1 | Migraine |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126471521 | 12647152 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126471521 | 12647152 | Aphasia | |
| 126471521 | 12647152 | Disorganised speech | |
| 126471521 | 12647152 | Disorientation | |
| 126471521 | 12647152 | Electroencephalogram abnormal | |
| 126471521 | 12647152 | Feeling abnormal | |
| 126471521 | 12647152 | Headache | |
| 126471521 | 12647152 | Impaired driving ability | |
| 126471521 | 12647152 | Impulsive behaviour | |
| 126471521 | 12647152 | Memory impairment | |
| 126471521 | 12647152 | Reading disorder | |
| 126471521 | 12647152 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126471521 | 12647152 | 1 | 2011 | 20151022 | 0 |